Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Sep;78(3):689–695. doi: 10.1172/JCI112628

Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

E C Böttger, T Hoffmann, U Hadding, D Bitter-Suermann
PMCID: PMC423652  PMID: 2427541

Abstract

Guinea pigs genetically deficient in the second (C2) or fourth component of complement (C4) generally appear healthy in contrast to humans with a C2 or C4 deficiency. However, upon investigation of these genetic deficiencies in guinea pigs for signs of dysregulation in the humoral immune system and especially autoantibodies, many complement-deficient guinea pigs (greater than 50%) had elevated levels of serum IgM and higher concentrations of anti-hapten (dinitrophenyl) antibodies as signs of polyclonally stimulated antibody synthesis. In addition, a significant number of the complement-deficient animals, on average 30%, had IgM rheumatoid factors in their sera compared with less than 1% of the normal animals. These observations, therefore, indicate that guinea pigs, genetically deficient in C2 or C4, show characteristics of immune complex disease in general.

Full text

PDF
689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V. Complement deficiency states. Medicine (Baltimore) 1978 Jan;57(1):1–23. doi: 10.1097/00005792-197801000-00001. [DOI] [PubMed] [Google Scholar]
  2. Aguado M. T., Lambris J. D., Tsokos G. C., Burger R., Bitter-Suermann D., Tamerius J. D., Dixon F. J., Theofilopoulos A. N. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b. J Clin Invest. 1985 Oct;76(4):1418–1426. doi: 10.1172/JCI112119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alper C. A., Rosen F. S. Inherited deficiencies of complement proteins in man. Springer Semin Immunopathol. 1984;7(2-3):251–261. doi: 10.1007/BF01893022. [DOI] [PubMed] [Google Scholar]
  4. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bitter-Suermann D., Hoffmann T., Burger R., Hadding U. Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig. J Immunol. 1981 Aug;127(2):608–612. [PubMed] [Google Scholar]
  6. Bitter-Suermann D., Peters H., Jürs M., Nehrbass R., Montenegro M., Timmis K. N. Monoclonal antibody detection of IncF group plasmid-encoded TraT protein in clinical isolates of Escherichia coli. Infect Immun. 1984 Nov;46(2):308–313. doi: 10.1128/iai.46.2.308-313.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bloch-Shtacher N., Hirschhorn K., Uhr J. W. The response of lymphocytes from non-immunized humans to antigen-antibody complexes. Clin Exp Immunol. 1968 Nov;3(9):889–899. [PMC free article] [PubMed] [Google Scholar]
  8. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  9. Budman D. R., Merchant E. B., Steinberg A. D., Doft B., Gershwin M. E., Lizzio E., Reeves J. P. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum. 1977 Apr;20(3):829–833. doi: 10.1002/art.1780200312. [DOI] [PubMed] [Google Scholar]
  10. Burger R., Deubel U., Hadding U., Bitter-Suermann D. Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies. J Immunol. 1982 Nov;129(5):2042–2050. [PubMed] [Google Scholar]
  11. Burger R., Shevach E. M. Evaluation of the role of C4 in the cellular immune response in vitro. J Immunol. 1979 Jun;122(6):2388–2394. [PubMed] [Google Scholar]
  12. Böttger E. C., Hoffmann T., Hadding U., Bitter-Suermann D. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J Immunol. 1985 Dec;135(6):4100–4107. [PubMed] [Google Scholar]
  13. Carroll M. C., Campbell R. D., Bentley D. R., Porter R. R. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature. 1984 Jan 19;307(5948):237–241. doi: 10.1038/307237a0. [DOI] [PubMed] [Google Scholar]
  14. Cohen B. E., Green I., Davie J. M. Immunologic tolerance in C4 deficient guinea pigs. J Immunol. 1973 Feb;110(2):608–611. [PubMed] [Google Scholar]
  15. Cooper N. R., Jensen F. C., Welsh R. M., Jr, Oldstone M. B. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med. 1976 Oct 1;144(4):970–984. doi: 10.1084/jem.144.4.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Daha M. R., Hazevoet H. M., van Es L. A. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus. Clin Exp Immunol. 1984 Jun;56(3):614–620. [PMC free article] [PubMed] [Google Scholar]
  17. Daniels C. A., Borsos T., Rapp H. J., Snyderman R., Notkins A. L. Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A. 1970 Mar;65(3):528–535. doi: 10.1073/pnas.65.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ellman L., Green I., Judge F., Frank M. M. In vivo studies in C4-deficient guinea pigs. J Exp Med. 1971 Jul 1;134(1):162–175. doi: 10.1084/jem.134.1.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Furuichi K., Kato M., Nakamura T., Koyama J. Preferential production of IgG2 anti-hapten antibody in guinea pigs immunized with 2,4-dinitrophenylated lipopolysaccharides of Escherichia coli. J Biochem. 1974 Nov;76(5):1147–1149. [PubMed] [Google Scholar]
  20. Gaither T. A., Alling D. W., Frank M. M. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol. 1974 Aug;113(2):574–583. [PubMed] [Google Scholar]
  21. Hobbs M. V., Morgan E. L., Baker N. L., Weigle W. O. Regulation of antibody responses by rheumatoid factor. I. Polyclonal activation of human B cells by rheumatoid factor-containing preparations from seropositive plasma. J Immunol. 1985 Jan;134(1):223–229. [PubMed] [Google Scholar]
  22. Izui S., Eisenberg R. A., Dixon F. J. IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol. 1979 May;122(5):2096–2102. [PubMed] [Google Scholar]
  23. Izui S., Eisenberg R. A., Dixon F. J. Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides. J Exp Med. 1981 Feb 1;153(2):324–338. doi: 10.1084/jem.153.2.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Izui S., Kobayakawa T., Zryd M. J., Louis J., Lambert P. H. Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice; II. Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal B lymphocyte activators. J Immunol. 1977 Dec;119(6):2157–2162. [PubMed] [Google Scholar]
  25. Izui S., McConahey P. J., Dixon F. J. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol. 1978 Dec;121(6):2213–2219. [PubMed] [Google Scholar]
  26. Izui S., Zaldivar N. M., Scher I., Lambert P. H. Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice. I. Anti-DNA induction by LPS without significant release of DNA in circulating blood. J Immunol. 1977 Dec;119(6):2151–2156. [PubMed] [Google Scholar]
  27. KUNKEL H. G., MULLER-EBERHARD H. J., FUDENBERG H. H., TOMASI T. B. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest. 1961 Jan;40:117–129. doi: 10.1172/JCI104224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. KUNKEL H. G., TAN E. M. AUTOANTIBODIES AND DISEASE. Adv Immunol. 1964;27:351–395. doi: 10.1016/s0065-2776(08)60711-7. [DOI] [PubMed] [Google Scholar]
  29. Kallenberg C. G., Limburg P. C., Van Slochteren C., Van der Woude F. J., The T. H. B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol. 1983 Aug;53(2):371–383. [PMC free article] [PubMed] [Google Scholar]
  30. La Via M. F., La Via D. S. Studies on Fc receptor function. I. IgG-mediated inhibition of B lymphocyte activation by T-dependent and T-independent antigens. Cell Immunol. 1978 Sep;39(2):297–306. doi: 10.1016/0008-8749(78)90105-3. [DOI] [PubMed] [Google Scholar]
  31. Lindmark R., Thorén-Tolling K., Sjöquist J. Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera. J Immunol Methods. 1983 Aug 12;62(1):1–13. doi: 10.1016/0022-1759(83)90104-7. [DOI] [PubMed] [Google Scholar]
  32. Miller G. W., Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975 Feb;72(2):418–422. doi: 10.1073/pnas.72.2.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morgan E. L., Weigle W. O. Polyclonal activation of murine B lymphocytes by immune complexes. J Immunol. 1983 Mar;130(3):1066–1070. [PubMed] [Google Scholar]
  34. Naama J. K., Holme E., Hamilton E., Whaley K. Prevention of immune precipitation by purified components of the alternative pathway. Clin Exp Immunol. 1985 Apr;60(1):169–177. [PMC free article] [PubMed] [Google Scholar]
  35. Natvig J. B., Gaarder P. I., Turner M. W. IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol. 1972 Oct;12(2):177–184. [PMC free article] [PubMed] [Google Scholar]
  36. Ochs H. D., Wedgwood R. J., Frank M. M., Heller S. R., Hosea S. W. The role of complement in the induction of antibody responses. Clin Exp Immunol. 1983 Jul;53(1):208–216. [PMC free article] [PubMed] [Google Scholar]
  37. Panush R. S., Bianco N. E., Schur P. H. Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis. Arthritis Rheum. 1971 Nov-Dec;14(6):737–747. doi: 10.1002/art.1780140609. [DOI] [PubMed] [Google Scholar]
  38. Papoian R., Pillarisetty R., Talal N. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology. 1977 Jan;32(1):75–79. [PMC free article] [PubMed] [Google Scholar]
  39. Primi D., Hammarström L., Smith C. I., Möller G. Characterization of self-reactive B cells by polyclonal B-cell activators. J Exp Med. 1977 Jan 1;145(1):21–30. doi: 10.1084/jem.145.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ryan J. L., Henkart P. A. Fc receptor-mediated inhibition of murine B-lymphocyte activation. J Exp Med. 1976 Sep 1;144(3):768–775. doi: 10.1084/jem.144.3.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schifferli J. A., Peters D. K. Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromes. Lancet. 1983 Oct 22;2(8356):957–959. doi: 10.1016/s0140-6736(83)90464-6. [DOI] [PubMed] [Google Scholar]
  42. Schur P. H. Complement and lupus erythematosus. Arthritis Rheum. 1982 Jul;25(7):793–798. doi: 10.1002/art.1780250715. [DOI] [PubMed] [Google Scholar]
  43. Smith H. R., Steinberg A. D. Autoimmunity--a perspective. Annu Rev Immunol. 1983;1:175–210. doi: 10.1146/annurev.iy.01.040183.001135. [DOI] [PubMed] [Google Scholar]
  44. Soderberg L. S., Coons A. H. Complement-dependent stimulation of normal lymphocytes by immune complexes. J Immunol. 1978 Mar;120(3):806–811. [PubMed] [Google Scholar]
  45. Steblay R. W., Rudofsky U. Spontaneous renal lesions and glomerular deposits of IgG and complement in guinea pigs. J Immunol. 1971 Oct;107(4):1192–1196. [PubMed] [Google Scholar]
  46. Takahashi M., Takahashi S., Brade V., Nussenzweig V. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway. J Clin Invest. 1978 Aug;62(2):349–358. doi: 10.1172/JCI109135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
  48. Theofilopoulos A. N., Shawler D. L., Eisenberg R. A., Dixon F. J. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med. 1980 Feb 1;151(2):446–466. doi: 10.1084/jem.151.2.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Torrigiani G., Roitt I. M. Antiglobulin factors in sera from patients with rheumatoid arthritis and normal subjects. Quantitative estimation in different immunoglobulin classes. Ann Rheum Dis. 1967 Jul;26(4):334–340. doi: 10.1136/ard.26.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES